CytomX (CTMX) 2025 Earnings Outlook for Investors Worldwide
CytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
Compare rebalancing frequency between index funds and target-date funds and what that means for risk, fees, and long-term performance. A quick look at when to expect adjustments.
28,361 articlesCytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
A routine bank alert turned into a high-stakes investigation when authorities traced suspicious activity to two suspe...
A new milestone for obesity treatment arrives as Novo Nordisk's Wegovy Pill hits 3 million prescriptions. This articl...
In late June 2026, XRP and XLM are both testing breakout attempts after weeks of consolidation. Neither has confirmed...
Tech stocks regain momentum as data-center spending reshapes the market. Oracle stands out as a potential upside surp...
As ICE activity rises in 2026, HR teams rely on three critical documents that decide what they may or must not do dur...
The U.S. government is backing quantum startups with billions. Here’s how that move could affect stock selection, ris...
Tesla’s 2026 year foundational growth centers on ramping four key initiatives that lay the groundwork for the next wa...
Retirees choosing Medigap plans must weigh long-term out-of-pocket costs, not just monthly premiums, as healthcare ex...
A hospital stay can end with Medicare denying skilled nursing facility coverage if the stay is classified as observat...
Chipotle faces its first full year of negative comps while McDonald’s leads with traffic recovery and value pricing. ...
Taiwan Semiconductor's Q2 report is due July 16, shaping AI capex bets. Five stocks stand out as potential winners or...